Form 4: Agilon Health CTO Girish Venkatachaliah Reports Stock Transactions

Girish Venkatachaliah, Chief Technology Officer of Agilon Health, reports acquisition of restricted stock units and options, as well as shares withheld for tax obligations.

Summary

• Girish Venkatachaliah, the Chief Technology Officer of Agilon Health, Inc. (AGL), filed a Form 4 detailing changes in beneficial ownership.
• On April 15, 2024, Venkatachaliah acquired 112,108 shares of common stock through restricted stock units (RSUs) at $0, vesting in four equal installments annually from that date, contingent upon continued employment.
• Also on April 15, 2024, Venkatachaliah acquired options to buy 184,502 shares of common stock at an exercise price of $4.46, vesting in four equal installments annually from that date, contingent upon continued employment, and expiring on April 15, 2034.
• On April 14, 2024, 3,056 shares of common stock were withheld by Agilon Health at a price of $4.95 to cover income tax obligations related to the settlement of RSUs.
• Following these transactions, Venkatachaliah directly owns 149,002 shares of common stock and 184,502 options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing reflecting compensation and tax obligations.

Positives

• The acquisition of restricted stock units and options indicates confidence in the company's future performance from a key executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by increasing the number of shares outstanding over time as RSUs vest and options are exercised.

Key Dates